Better health and ageing for all Australians

The National Diabetes Services Scheme Agreement

Schedule 11: Scheme reporting requirements

Up to National Diabetes Services Scheme

| TOC |

Diabetes Australia is required to provide, in conjunction with the annual Financial Statements set out at clause 9 of the Agreement, the following items in a progress report against the objectives of the Scheme. In accordance with the annual Financial Statements, this report should be submitted by 30 September of each year of the Agreement or within 60 days of earlier termination of the Agreement.
A Final Report addressing this reporting criteria will also be submitted at the end of the Agreement.

11.1 Financial reporting

11.1.1 Diabetes Australia must provide the Reports as specified in clause 9 of the Agreement.

11.1.2 In addition, the following financial information is also required:

  1. Funds on hand at the beginning of the reporting period;
  2. expenditure on Product during the reporting period;
  3. expenditure of the Product Supply and Delivery Grant during the reporting period;
  4. expenditure of the Registrant Services Grant during the reporting period;
  5. expenditure of the Strategic Development Grant during the reporting period;
  6. expenditure on National Projects during the reporting period;\
  7. expenditure on Information Technology Projects during the reporting period;
  8. Patient Contributions received during the reporting period;
  9. Funds received during the reporting period;
  10. Funds on hand at the end of the reporting period; and
  11. carry-over into next reporting period.

11.2 Product supply reports (Schedule 3)

11.2.1 Diabetes Australia is required to provide the Department with reports on Product Supply records on an annual basis.

11.2.2 Each report must contain the following information:

  1. quantity of Product supplied to Registrants, by Units of Product, for each item covered by the Scheme, including Blood Glucose Test Strips, Urine testing strips, Sharps – consisting pen needles and syringes, and Insulin pump consumables (lines, adaptors and reservoirs); the ex-manufacturer cost of those Products; the value of remuneration to Diabetes Australia paid in accordance with Schedule 2 of this Agreement; Registrant Contributions collected in respect of those Products as described at clauses 2.2 and 2.3; and cost to Government;
  2. level of product ordering by postcode;
  3. the number of Diabetes Australia Agent Outlets by postcode and per postcode population;
  4. the proportion of Products supplied directly, by mail or by courier, over the counter, broken down Agent Outlets, and nationally and by State and Territory; and
  5. the number of occasions complaints were received in regards to not receiving Product as specified in 3.5.4 (b).

11.3 Scheme access reports (Schedule 4)

11.3.1 Diabetes Australia must provide the Department with reports on its access arrangements on an annual basis.11.3.2 Each report must contain the following:
  1. number of Agents or Diabetes Australia shop-fronts located in each State / Territory;
  2. number of Sub-agents located in the State / Territory;
  3. PhAria rating of each Outlet;
  4. annual review of Sub-agent activity in each State / Territory;
  5. annual review of Sub-agent expansion in each State / Territory, including:
    1. number of Sub-Agency advertisements each reporting period;
    2. number of sub-agency applications received (including type – pharmacy, non pharmacy) each reporting period;
    3. number of successful sub-agency applications;
    4. number of unsuccessful sub-agency applications and why; and
    5. number of appeals lodged regarding unsuccessful sub-agency applications;
  6. summary of performance against required reviews/objectives specific to clause 4.7;
  7. status of Sub-agent Connectivity rollout and a report on the effectiveness of the system;
  8. the number of Sub-Agency applicants over the reporting period in each State/Territory; and
  9. any other matters considered relevant including areas of concern or areas of continuous improvement.

11.4 Registratn services reports (Schedule 5)

11.4.1 Diabetes Australia must provide the Department with reports on its provision of Registrant Services arrangements on an annual basis against the annual element of the Registrant Services Plan outlined in 5.8.

11.4.2 Each report must contain the following:

  1. number of Registrants, broken down into:
    1. national and by State/Territory;
    2. Type 1, Type 2 insulin requiring and non-insulin requiring, GDM insulin requiring and non-insulin using, other diabetes insulin requiring and non-insulin requiring and total Registrants (GDM split to be provided after the first six months of the Agreement);
    3. by relevant age categories and by diabetes type;
    4. new registrant trend compared to previous years;
    5. number of registrants who ordered Product within the previous 3, 6 and 12 months, by type as set out in (ii);
  2. number of occasions on which information materials were supplied to or accessed by Registrants or other persons, including:
    1. printed materials (including number of Starter Packs issued), on a State and Territory breakdown;
    2. number of calls to Scheme Registrant 1300 help line on a State and Territory breakdown;
    3. number of hits to the Scheme website;
  3. number and proportion of items of information material distributed:
    1. to indigenous Australian Registrants identifiable from the database, or their healthcare providers;
    2. in languages other than English; and
  4. numbers of Registrants who have had access to programs and information developed under the Strategic Development Grant program that have been distributed as part of National Projects or have been rolled into Registrant services in the reporting year.

11.5 Strategic development reports (Schedule 6)

11.5.1 Diabetes Australia is required to provide Strategic Development Grant program reports on an annual basis.

11.5.2 Each report must contain the following:

  1. number of Strategic Development Projects for the year;
  2. number of projects completed for the year;
  3. outline of projects that will be rolled out across the Scheme on a national basis;
  4. copies of any resources or materials developed and distributed to Scheme registrants during the period covered by the report;
  5. any other matters deemed relevant.

11.6 National Project Reports (Schedule 7)

11.6.1 Diabetes Australia is required to provide the Department with a National Projects Report on an annual basis.

11.6.2 Each report must contain the following information:

  1. a copy of the National Projects plan up to 30 June of the reporting period;
  2. number of National Projects undertaken for the year;
  3. outline of projects that will be rolled out across the Scheme on a national basis;
  4. copies of any resources or materials developed and distributed to Scheme Registrants during the period covered by the report; and
  5. any other matters deemed relevant as agreed by the Department and Diabetes Australia.

Top of page

11.7 Information technology report (Schedule 8)

11.7.1 Diabetes Australia is required to provide the Department with Information Technology reports on an annual basis.

11.7.2 Each report must contain the following:

  1. a copy of progress to date in line with Information Technology developments;
  2. summary of the strategic plan and any changes made to this plan; and
  3. annual costs attributed to Information Technology developments over the life of the Scheme.

11.8 Scheme KPI website reporting requirements

11.8.1 In addition to the reporting requirements above, Diabetes Australia will maintain its KPI website, undertaking to upload new information on a monthly basis for the following categories:

11.8.2 Cost of the Scheme

  1. the ex-manufacturer cost of Products on the Scheme;
  2. the value of remuneration to Diabetes Australia paid in accordance with Schedule 2 of this Agreement;
  3. Registrant Contributions collected in respect of those Products; and
  4. cost to Government.

11.8.3 Product
  1. quantity of Product supplied to Registrants, by Unit of Product, for each item covered by the Scheme, including blood and urine diagnostic agents, syringes, needles and insulin pump consumables;
  2. the proportion of Products supplied directly, by mail or by courier, over the counter, broken down by Sub-agents and Diabetes Australia Agent Outlets, and nationally and by State and Territory; and
  3. the number of Diabetes Australia Agent Outlets and Sub-agents by postcode and per population.

11.8.4 Registrants
  1. number of Registrants, broken down into:
    1. national and by State/Territory;
    2. Type 2 insulin using and non-insulin using, Type 1, GDM insulin using and non-insulin using and total Registrants (GDM split to be provided after the first six months of the Agreement), number of Registrants who utilise an insulin pump, number of Registrants who have indigenous status, number of registrants with a language other than English spoken at home;
    3. age range as presently exist on website;
  2. inactive and current Registrations;
  3. number of registrants who ordered Product within the previous12 months, by type (1 and 2 only) as set out in (ii); and
  4. percentage of Registrants who purchase Product.

11.8.5 Expansion of website capabilities

Diabetes Australia must also provide information on the website (on an annual basis for each financial year) for the following categories:

  1. number of Product groups sold by postcode;
  2. number of Units of Product (in PBS quantities) sold by postcode;
  3. number of Units of Product (in PBS quantities) sold by process order (not over the counter) by destination postcode; and
  4. number of Units of Product (in PBS quantities) sold by age range.

    | TOC |